Cardinal Capital Management Meridian Bioscience Inc Transaction History

Cardinal Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 08, 2019	SELL	$10.88 - $17.6 $339,543 - $549,260	-31,208 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$15.51 - $17.61 $17,619 - $20,004	1,136 Added 3.78%	31,208 $549,000
Q4 2018 Jan 15, 2019	BUY	$14.52 - $19.72 $16,843 - $22,875	1,160 Added 4.01%	30,072 $522,000
Q3 2018 Oct 25, 2018	SELL	$14.85 - $16.35 $594 - $654	-40 Reduced 0.14%	28,912 $430,000
Q2 2018 Jul 25, 2018	BUY	$13.8 - $16.8 $7,493 - $9,122	543 Added 1.91%	28,952 $460,000
Q1 2018 Apr 25, 2018	BUY	$13.8 - $16.2 $1,173 - $1,377	85 Added 0.3%	28,409 $403,000
Q4 2017 Feb 01, 2018	SELL	$13.55 - $15.8 $18,089 - $21,093	-1,335 Reduced 4.5%	28,324 $397,000
Q3 2017 Oct 24, 2017	BUY	$13.45 - $14.35 $398,913 - $425,606	29,659	29,659 $424,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

Stay updated on Cardinal Capital Management with notifications on news.